 |
인쇄하기
취소
|
Huons files new PE drug application for marketing approval with KFDA
Huons announced last Friday that it has filed a marketing application for its new oral premature ejaculation (PE) drug (clomipramine HCl) with the Korea Food and Drug Administration.
Jointly developed by CTC Bio, clomipramine is a tricylic antidepresasnt to treat premature ejaculation
“The results of Phase 3 trial found that it has better efficacy with less serious side effects,” said a c...
Jointly developed by CTC Bio, clomipramine is a tricylic antidepresasnt to treat premature ejaculation
“The results of Phase 3 trial found that it has better efficacy with less serious side effects,” said a c...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.